Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Abroad (travel likely)RecruitingPHASE4
Conditions
Multiple Sclerosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Novartis Investigative Site, Kaohsiung City, Taiwan
Novartis Investigative Site, Taichung, Taiwan
Novartis Investigative Site, Tainan, Taiwan
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Taipei, Taiwan
Novartis Investigative Site, Taoyuan, Taiwan
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals